Moreover, reduced EET bioavailability has been linked to endothelial dysfunction, oxidative stress, and adverse cardiac remodeling in HF (CYP2J2 Modulates Diverse Transcriptional Programs in Adult Human Cardiomyocytes). The gene discussed is CYP2J2; the disease is endothelial dysfunction.